Clinical Trial Update: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for an IL-8 receptor-modified CD70 CAR T cell therapy in adults with glioblastoma. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• IL-8 receptor-modified CD70 CAR T cell therapy

Snippet

Sponsor: University of Florida | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING